“There aren’t any major flaws in the dataset,” they wrote. VKX2735 also looks more effective than Roche’s CT-996, the next most efficacious oral incretin, they wrote, which achieved a 7.3% weight loss ...

Viking Therapeutics reported an 8.2% weight loss with VK2735, but a sell-off followed. Read why VKTX stock's long-term ...

These comments follow close on the heels of reports about Roche's (OTCQX:RHHBY) experimental obesity pill CT-996, which was linked to significant side effects in early trials. These included ...

Demand for weight loss drugs targeting GLP-1 has exploded in recent years, leading to disruptions in supply chains. Here are ...

Detailed price information for Structure Therapeutics Inc (GPCR-Q) from The Globe and Mail including charting and trades.

Thanks to its savvy Carmot acquisition, Roche is saving millions of dollars in R&D weight loss drug development, and it's getting results in trials from its pill-based weight loss drug CT-996 ...

We’ve also passed on companies with next-wave obesity drugs in very early stages of development or ones deemed farther away from market, such as Roche’s CT-996, also orally administered ...

The acquisition added a differentiated incretin portfolio with three candidates — CT-388, CT-996 and CT-868 — in its pipeline. However, the stock took a hit last month when RHHBY presented ...

We think daily oral GLP-1 CT-996—which led to 6.1% placebo-adjusted weight loss after just four weeks of treatment—is poised to enter phase 2 in 2025 and could launch as a differentiated oral ...

Shares of Novo Nordisk and Eli Lilly took a hit after Swiss pharma giant Roche posted positive results for its experimental weight loss pill. Roche said early Wednesday morning that its weight ...

"There aren't any major flaws in the dataset," they wrote. VKX2735 also looks more effective than Roche's CT-996, the next most efficacious oral incretin, they wrote, which achieved a 7.3% weight ...

In an interview with Yahoo Finance, Deutsche Bank analyst James Shin singled out Roche’s (OTCMKTS: RHHBY) drug “CT-996” when asked about which oral weight loss drug he sees as the biggest ...